167 related articles for article (PubMed ID: 36401718)
41. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance.
Kaldor J; Shugg D; Young B; Dwyer T; Wang YG
Int J Cancer; 1993 Apr; 53(6):886-91. PubMed ID: 8473047
[TBL] [Abstract][Full Text] [Related]
42. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group.
Karagas MR; Greenberg ER; Spencer SK; Stukel TA; Mott LA
Int J Cancer; 1999 May; 81(4):555-9. PubMed ID: 10225444
[TBL] [Abstract][Full Text] [Related]
43. Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma.
Qureshi AA; Laden F; Colditz GA; Hunter DJ
Arch Intern Med; 2008 Mar; 168(5):501-7. PubMed ID: 18332296
[TBL] [Abstract][Full Text] [Related]
44. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010.
Rudolph C; Schnoor M; Eisemann N; Katalinic A
J Dtsch Dermatol Ges; 2015 Aug; 13(8):788-97. PubMed ID: 26213814
[TBL] [Abstract][Full Text] [Related]
45. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
46. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
47. Site distribution of different types of skin cancer: new aetiological clues.
Franceschi S; Levi F; Randimbison L; La Vecchia C
Int J Cancer; 1996 Jul; 67(1):24-8. PubMed ID: 8690520
[TBL] [Abstract][Full Text] [Related]
48. Cutaneous β HPVs, Sun Exposure, and Risk of Squamous and Basal Cell Skin Cancers in Australia.
Kricker A; Weber MF; Pawlita M; Sitas F; Hodgkinson VS; Rahman B; van Kemenade CH; Armstrong BK; Waterboer T
Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):614-624. PubMed ID: 34933956
[TBL] [Abstract][Full Text] [Related]
49. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.
Yanik EL; Pfeiffer RM; Freedman DM; Weinstock MA; Cahoon EK; Arron ST; Chaloux M; Connolly MK; Nagarajan P; Engels EA
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):998-1007. PubMed ID: 28377416
[No Abstract] [Full Text] [Related]
50. Epidemiology of basal cell carcinoma and squamous cell carcinoma of the pinna.
Ahmad I; Das Gupta AR
J Laryngol Otol; 2001 Feb; 115(2):85-6. PubMed ID: 11320842
[TBL] [Abstract][Full Text] [Related]
51. XPA, haplotypes, and risk of basal and squamous cell carcinoma.
Miller KL; Karagas MR; Kraft P; Hunter DJ; Catalano PJ; Byler SH; Nelson HH
Carcinogenesis; 2006 Aug; 27(8):1670-5. PubMed ID: 16513681
[TBL] [Abstract][Full Text] [Related]
52. Risk of skin cancer in patients with HIV: A Danish nationwide cohort study.
Omland SH; Ahlström MG; Gerstoft J; Pedersen G; Mohey R; Pedersen C; Kronborg G; Larsen CS; Kvinesdal B; Gniadecki R; Obel N; Omland LH
J Am Acad Dermatol; 2018 Oct; 79(4):689-695. PubMed ID: 29588249
[TBL] [Abstract][Full Text] [Related]
53. Inflammatory Dietary Patterns and Risk of Keratinocyte Cancers in Kidney Transplant Recipients: Prospective Cohort Study.
Shao E; Green AC; Miura K
Dermatology; 2021; 237(6):1029-1034. PubMed ID: 32966976
[TBL] [Abstract][Full Text] [Related]
54. Socioeconomic status and non-melanoma skin cancer: a nationwide cohort study of incidence and survival in Denmark.
Steding-Jessen M; Birch-Johansen F; Jensen A; Schüz J; Kjær SK; Dalton SO
Cancer Epidemiol; 2010 Dec; 34(6):689-95. PubMed ID: 20638927
[TBL] [Abstract][Full Text] [Related]
55. Incidence and risk factors for nonmelanoma skin cancer after heart transplantation.
Molina BD; Leiro MG; Pulpón LA; Mirabet S; Yañez JF; Bonet LA; Vilchez FG; Delgado JF; Manito N; Rábago G; Arizón JM; Romero N; Roig E; Blasco T; Pascual D; de la Fuente L; Muñiz J
Transplant Proc; 2010 Oct; 42(8):3001-5. PubMed ID: 20970593
[TBL] [Abstract][Full Text] [Related]
56. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995.
Plesko I; Severi G; Obsitníková A; Boyle P
Neoplasma; 2000; 47(3):137-42. PubMed ID: 11043834
[TBL] [Abstract][Full Text] [Related]
57. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
58. Parkinson's Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study.
Lerman S; Amichai B; Weinstein G; Shalev V; Chodick G
Neuroepidemiology; 2018; 50(3-4):168-173. PubMed ID: 29566384
[TBL] [Abstract][Full Text] [Related]
59. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97.
Koh D; Wang H; Lee J; Chia KS; Lee HP; Goh CL
Br J Dermatol; 2003 Jun; 148(6):1161-6. PubMed ID: 12828744
[TBL] [Abstract][Full Text] [Related]
60. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
